- Oral presentation
- Open Access
Multiparametric mapping in the diagnosis and management of cardiac transplant rejection: a prospective, histologically-validated study
Journal of Cardiovascular Magnetic Resonance volume 18, Article number: O67 (2016)
Routine surveillance endomyocardial biopsies (EMBx) in heart transplant recipients are associated with serious complications. CMR-based tissue characterisation using T1 and T2 mapping sequences accurately and non-invasively diagnoses extracellular space expansion and interstitial oedema and theoretically, holds potential for the detection of acute cardiac rejection and chronic interstitial myocardial fibrosis associated with chronic rejection. This study aimed to determine the diagnostic role of novel T1- and T2-mapping sequences in heart transplant recipients.
Patients underwent CMR within 24 hours of their surveillance or clinically-indicated EMBx starting from six weeks after transplantation. The native T1 maps were acquired using Modified Look-Locker Inversion recovery (MOLLI) sequence in a single mid-ventricular short axis slice (Philips Medical Systems, Best, Netherlands). T1 values were calculated by fitting an exponential curve to measured data from 8 different phases after manual offline motion correction. The T2 values were measured using a respiratory-navigated black-blood turbo spin echo sequence in a single mid-short-axis slice. The EMBx tissue was stained with Masson's trichrome stain to assess the degree of fibrosis and was graded for rejection degree according to International Society of Heart and Lung Transplantation (ISHLT) guidelines.
Of 84 scans, 42 biopsies were ISHLT grade 0 (group 0), 27 grade 1R (group 1), 2 grade 2R, 7 grade 3R or antibody mediated rejection and 6 clinically-diagnosed rejections (group 2). T1 values were significantly higher in group 2 (n = 15, 1033 (10.42); mean (SEM)) compared to group 0 (n = 27, 983 (7.18); p = 0.0001) and group 1 (n = 42, 995.2 (17. 06); p = 0.01). There was a strong correlation between T1 values measured exclusively in the interventricular septum vs circumferentially (R2 0.886, p < 0.0001). Out of total 59 samples stained with Masson's trichrome stain, 18 had no visible fibrosis and 41 had quantifiable fibrosis; grade 1 (5-10%), grade 2 (10-30%) and grade 3 (>40%). The patients with higher grade interstitial fibrosis had higher T1 values (p < 0.05). The T2 values were also significantly higher in rejection group 2 (n = 13, 67.59 (1.95)) vs. group 1 (n = 26, 56.07 (1.266); p < 0.0001) and group 0 (n = 43, 53.60 (0.687); p < 0.0001).
Using 970 msec as a cut off on ROC analysis, T1 had sensitivity of 100% and specificity of 42% for the diagnosis of acute rejection using histology as the gold standard. Using a value of 60, T2 had sensitivity of 92% and specificity of 84%. The combination of T2 and T1 mapping resulted in a ROC curve area of 0.946 with 100% sensitivity, 85% specificity, a negative predictive value of 100% and a positive predictive value of 54% (low prevalence).
Multiparametric mapping using CMR-based T1- and T2-mapping displays high sensitivity and specificity in the detection of cardiac allograft rejection and holds promise to reduce the dependency on invasive EMBx after cardiac transplantation.
Rights and permissions
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Imran, M., Wang, L., McCrohon, J. et al. Multiparametric mapping in the diagnosis and management of cardiac transplant rejection: a prospective, histologically-validated study. J Cardiovasc Magn Reson 18 (Suppl 1), O67 (2016). https://doi.org/10.1186/1532-429X-18-S1-O67
- Heart Transplant Recipient
- Antibody Mediate Rejection
- Cardiac Allograft Rejection
- Rejection Group
- Cardiac Rejection